
Many biopharmaceutical companies have increased their emphasis on innovative technologies and data sciences to stimulate a digital transformation across R&D. Underlying successful digital transformations, is the critical need for R&D organizations to leverage information assets to enable enhanced insights, decision making, and process automation.